The developer of Russia’s Sputnik V coronavirus vaccine said Friday its shot had been approved for use in the Philippines, becoming the 52nd country to give the green light to the Russian jab. Russia’s sovereign wealth fund, which backed the…
Read More
AstraZeneca buying drug developer Alexion for $39 billion
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said Saturday it’s using a combination…
Read More